标题 |
First-in-class, orally bioavailable KRAS(G12V)(ON) tri-complex inhibitors, as single agents and in combinations, drive profound anti-tumor activity in preclinical models of KRAS(G12V) mutant cancers
同类首创的口服生物可利用KRAS(G12V)(ON)三复合抑制剂,作为单一药物和组合,在KRAS(G12V)突变癌症的临床前模型中驱动深远的抗肿瘤活性
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
期刊:Brain Research 作者:Yoshimasa Kinoshita; Hirohiko Matsumura; H Igisu; Akira Yokota 出版日期:2000-08-01 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |